N/A
N=300
Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).
Type 1 Diabetes Mellitus
Bottom Line
View on ClinicalTrials.gov: NCT03478254 ↗Enrolled (actual)
300
Serious AEs
—
Results posted
Jan 2021
Primary outcome: Primary: Adherence to Regional Guidelines for the Immunization of Adults With Type 1 Diabetes Mellitus (T1DM — 165; 54; 51; 30 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Influenza vaccination (Biological); Pneumococcal vaccination (Biological); Hepatitis B Virus (HBV) vaccination (Biological)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Jesús Moreno Fernández
- Primary completion
- Dec 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Regional Guidelines for the Immunization of Adults With Type 1 Diabetes Mellitus (T1DM |
165; 54; 51; 30 | — |
| SECONDARY Patient Age According to Vaccination Status |
43.5; 39.7; 28.3; 44.5 | — |
| SECONDARY Number of Participants Who Have Taken Related Sick Leaves |
17 | — |
Summary
Observational study about adherence to guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.
Eligibility Criteria
Inclusion Criteria
- ≥18 years of age.
- Diagnosed of Type 1 Diabetes Mellitus.
- Be attended in Ciudad Real General University Hospital.
Exclusion Criteria
- Less than 18 years old.
- Other types of diabetes mellitus.
Data sourced from ClinicalTrials.gov (NCT03478254). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.